Leerink Partnrs Expects Increased Earnings for Schrodinger

Key Points

• Analysts at Leerink Partners have increased their Q3 2025 EPS estimates for Schrodinger, Inc. to ($0.63), up from the previous forecast of ($0.69).
• Schrodinger reported earnings per share of ($0.59) for its latest quarter, exceeding analysts' expectations by $0.24.
• The company's revenue increased by 15.7% year-over-year, reaching $54.76 million, surpassing analyst estimates of $52.03 million.

Schrodinger, Inc. (NASDAQ:SDGR - Free Report) - Analysts at Leerink Partnrs raised their Q3 2025 earnings per share (EPS) estimates for shares of Schrodinger in a research note issued on Wednesday, August 6th. Leerink Partnrs analyst M. Foroohar now expects that the company will post earnings per share of ($0.63) for the quarter, up from their previous forecast of ($0.69). The consensus estimate for Schrodinger's current full-year earnings is ($2.37) per share. Leerink Partnrs also issued estimates for Schrodinger's Q4 2025 earnings at ($0.12) EPS, FY2025 earnings at ($2.16) EPS, FY2026 earnings at ($1.78) EPS, FY2027 earnings at ($1.97) EPS, FY2028 earnings at ($0.60) EPS and FY2029 earnings at ($0.99) EPS.

A number of other analysts have also recently commented on SDGR. KeyCorp lowered their price target on Schrodinger from $32.00 to $30.00 and set an "overweight" rating for the company in a research report on Monday, July 14th. Morgan Stanley began coverage on Schrodinger in a report on Thursday, July 3rd. They issued an "equal weight" rating and a $28.00 price objective for the company. Finally, Barclays began coverage on Schrodinger in a report on Thursday. They issued an "overweight" rating and a $25.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Schrodinger has a consensus rating of "Moderate Buy" and a consensus price target of $31.20.

Schrodinger Stock Performance

SDGR stock traded down $0.27 on Monday, hitting $19.58. 2,807,646 shares of the company's stock were exchanged, compared to its average volume of 1,156,983. The firm has a 50 day moving average price of $21.33 and a two-hundred day moving average price of $22.42. Schrodinger has a 12-month low of $16.60 and a 12-month high of $28.47. The stock has a market cap of $1.44 billion, a P/E ratio of -7.88 and a beta of 1.67.

Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.83) by $0.24. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%. The business had revenue of $54.76 million for the quarter, compared to the consensus estimate of $52.03 million. During the same period last year, the business posted ($0.66) EPS. The business's revenue was up 15.7% compared to the same quarter last year.

Hedge Funds Weigh In On Schrodinger

Several institutional investors and hedge funds have recently modified their holdings of SDGR. Farther Finance Advisors LLC increased its stake in shares of Schrodinger by 347.4% in the 2nd quarter. Farther Finance Advisors LLC now owns 1,284 shares of the company's stock valued at $26,000 after purchasing an additional 997 shares in the last quarter. Point72 Hong Kong Ltd purchased a new position in shares of Schrodinger in the 4th quarter valued at about $27,000. Bayforest Capital Ltd purchased a new position in shares of Schrodinger in the 2nd quarter valued at about $30,000. ANTIPODES PARTNERS Ltd purchased a new stake in Schrodinger during the 1st quarter worth approximately $37,000. Finally, PNC Financial Services Group Inc. increased its stake in Schrodinger by 29.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,956 shares of the company's stock worth $58,000 after buying an additional 680 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Schrodinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.